Zepp Health Corporation
ZEPP · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,333,451 | $2,497,513 | $4,215,626 | $6,169,190 |
| % Growth | -46.6% | -40.8% | -31.7% | – |
| Cost of Goods Sold | $820,570 | $1,843,811 | $3,398,405 | $4,880,452 |
| Gross Profit | $512,881 | $653,702 | $817,222 | $1,288,738 |
| % Margin | 38.5% | 26.2% | 19.4% | 20.9% |
| R&D Expenses | $337,074 | $364,534 | $526,205 | $508,412 |
| G&A Expenses | $181,409 | $0 | $0 | $0 |
| SG&A Expenses | $520,848 | $504,691 | $708,465 | $687,600 |
| Sales & Mktg Exp. | $339,192 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $857,922 | $869,224 | $1,234,669 | $1,196,012 |
| Operating Income | -$345,041 | -$215,522 | -$417,447 | $92,726 |
| % Margin | -25.9% | -8.6% | -9.9% | 1.5% |
| Other Income/Exp. Net | -$108,551 | -$21,701 | $56,338 | $53,059 |
| Pre-Tax Income | -$453,592 | -$237,223 | -$361,109 | $145,785 |
| Tax Expense | $99,993 | -$17,199 | -$67,032 | $10,606 |
| Net Income | -$554,133 | -$220,491 | -$293,372 | $136,019 |
| % Margin | -41.6% | -8.8% | -7% | 2.2% |
| EPS | -136.64 | -7.84 | -10.84 | 5.52 |
| % Growth | -1,642.9% | 27.7% | -296.4% | – |
| EPS Diluted | -136.64 | -7.84 | -10.84 | 5.24 |
| Weighted Avg Shares Out | 4,045 | 3,799 | 3,848 | 3,940 |
| Weighted Avg Shares Out Dil | 4,045 | 3,799 | 3,848 | 4,131 |
| Supplemental Information | – | – | – | – |
| Interest Income | $26,815 | $21,864 | $12,551 | $16,470 |
| Interest Expense | $40,543 | $47,790 | $58,002 | $44,303 |
| Depreciation & Amortization | $36,636 | $54,429 | $59,648 | $51,212 |
| EBITDA | -$345,662 | -$142,882 | -$261,426 | $200,803 |
| % Margin | -25.9% | -5.7% | -6.2% | 3.3% |